The status of gene therapy for brain tumors
- 24 January 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 7 (2) , 197-208
- https://doi.org/10.1517/14712598.7.2.197
Abstract
(2007). The status of gene therapy for brain tumors. Expert Opinion on Biological Therapy: Vol. 7, No. 2, pp. 197-208.Keywords
This publication has 117 references indexed in Scilit:
- Serial Passage through Human Glioma Xenografts Selects for a Δγ 1 34.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain TumorsJournal of Virology, 2006
- Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus VectorCancer Research, 2006
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisPublished by Elsevier ,2006
- Adeno-associated virus vectors: potential applications for cancer gene therapyCancer Gene Therapy, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Regulation of herpes simplex virus γ134.5 expression and oncolysis of diffuse liver metastases by Myb34.5Journal of Clinical Investigation, 2002
- Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene TherapyMolecular Imaging, 2002
- A Herpes Simplex Virus Type 1 γ34.5 Second-Site Suppressor Mutant That Exhibits Enhanced Growth in Cultured Glioblastoma Cells Is Severely Attenuated in AnimalsJournal of Virology, 2001
- p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastomaOncogene, 2000
- Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene deliveryGene Therapy, 2000